Br.027) lineage of the B.Br.013 group phylogenetic tree in (A), and the letter corresponds to MLVA genotypes indicated in Table 2 and in Additional file 4. Subclade and MLVA genotypes are also shown for the two Crimean isolates, indicated by an arrow pointing in the direction of the Crimean peninsula (upper left). To understand the relationship of the Georgian lineage to PI3K Inhibitor Library supplier other Eastern European lineages, we genotyped 132 geographically diverse group B.Br.013 isolates collected in Central and Eastern Europe across the B.Br.026 and B.Br.027 canSNP assays (Figure 2A, see additional file 3). All resulting genotypes from this analysis were phylogenetically consistent with no observed homoplasy. With just two exceptions,

all of these isolates were assigned to the B.Br.026 lineage. The exceptions were two isolates from the Crimean region of Ukraine that were assigned to the Georgian lineage. Subsequent, additional canSNP analyses assigned Hydroxychloroquine in vitro these two isolates to the basal B.Br.027/028 subclade within the Georgian lineage. These results indicate that the Georgian isolates, as well as the two isolates from Crimea, are phylogenetically distinct from the previously described F. tularensis subsp. holarctica

subpopulations. The subclades within the Georgian lineage did not display a differentiated phylogeographic pattern but, rather, were spatially dispersed in a mixed fashion throughout Eastern Georgia and the Crimean region of Ukraine (Figure 2B). The assignment of the Crimean isolates to the basal B.Br.027/028 subclade within the Georgian lineage (Figure 2A) confirms that this lineage is not geographically restricted to Georgia, and is RG7420 suggestive of a north to south dispersal pattern. That said, the overall geographic extent of the Georgian lineage is currently unknown due to the limited sampling in adjacent countries. Further discrimination using MLVA MLVA was used to examine genetic variation within each identified subclade of the Georgian lineage (Table 2; Additional file 4). Five unique MLVA genotypes were identified among the 25 Georgian

isolates (Table 2) that were distinct from the MLVA genotypes of strains found north of Georgia. Calculations of MLVA diversity (D = G/N) within each subclade (see methods for calculation) showed decreasing levels of diversity within higher resolution subclades (Figure 2A). The most basal Georgian subclade, B.Br.027/028 (D = 0.67) (Figure 2A), was comprised of a single Georgian isolate that was distinguishable from the two Crimean isolates in the same subclade due to a distinct MLVA genotype. There were three MLVA genotypes among the seven Georgian isolates within subclade B.Br.028/029 (D = 0.43). A single MLVA genotype was shared by all seven Georgian isolates in subclade B.Br.029/030 (D = 0.14), and the two other intermediate subclades (B.Br.030/031 and B.Br.031/032) contained only a single isolate each.

Occup Environ Med 63(2):113–120CrossRef Martimo KP, Shiri R, Miranda H, Ketola R, Varonen H, Viikari-Juntura E (2009) Self-reported productivity loss among workers with upper extremity disorders. Scand J Work Environ Health 35(4):301–308CrossRef Martimo KP, Shiri R, Miranda H, Ketola R, Varonen H, Viikari-Juntura E (2010) Effectiveness of an ergonomic intervention on the productivity of workers with upper-extremity

disorders—a randomized controlled trial. Scand J Work Environ Health 36(1):25–33CrossRef McEwen B (1998) Stress, adaptation and disease: allostasis and allostatic load. Ann NY Acad Sci 840(1):33–34CrossRef McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the relative risk in cohort studies and ICG-001 in vivo clinical trials of common outcomes. Am J Epidemiol 157(10):940–943CrossRef Neupane S, Virtanen P, Leino-Arjas P, Miranda H, Siukola A, Nygard CH (2012) Multi-site pain and working conditions Selleck PD0325901 as predictors of work

ability in a 4-year follow-up among food industry employees. Eur J Pain 3:444–451 Radkiewics PW-BM (2005) Psychometric properties of work ability index in the light of comparative survey study. Int Congr Ser 1280:304–309CrossRef Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology. Lippincott Williams & Wilkins, Philadelphia Saltin G (1968) Phychological analysis of middle-aged and older former athletes. Comparison with still active athletes of the same ages. Circulation 38(6):1104–1115CrossRef

Skov T, Deddens J, Petersen MR, Endahl L (1998) Prevalence proportion ratios: estimation Ibrutinib and hypothesis testing. Int J Epidemiol 27(1):91–95CrossRef Sluiter JK, Frings-Dresen MH (2008) Quality of life and illness perception in working and sick-listed chronic RSI patients. Int Arch Occup Environ Health 81(4):495–501CrossRef Statistics Sweden (2008) http://​www.​seb.​se Statistics Sweden (2010) http://​www.​seb.​se Statistics Sweden (2011) http://​www.​seb.​se Stefansson C (2006) Major public health problems-mental ill health. Scand J Public Health 34(Suppl 67):87–103CrossRef Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D (2003a) Cost of lost productive work time among US workers with depression. JAMA 289(23):3135–3144CrossRef Stewart WF, Ricci JA, Chee E, Morganstein D (2003b) Lost productive work time costs from health conditions in the United States: results from the American Productivity Audit. J Occup Environ Med 45(12):1234–1246CrossRef Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R (2003c) Lost productive time and cost due to common pain conditions in the US workforce.

PG=peptidoglyca;. ND=not determined; += presence; -=absence. (XLSX 19 KB) Additional file 4: Phylogenetic comparative analysis detailed dates. (DOCX 15 KB) References 1. Vollmer W, Blanot D, de Pedro MA: Peptidoglycan structure and Acalabrutinib price architecture. FEMS Microbiol Rev 2008, 32:149–167.PubMedCrossRef 2. Gram HC: The differential staining of Schizomycetes in tissue sections and in dried preparations. Furtschitte der Medicin 1884, 2:185–189. 3. Wayne LG, Kubica GP: The Mycobacteria. In Bergey’s Manual of Systematic

Bacteriology. Volume 2. 1st edition. Edited by: Sneath PHA, Mair NS, Sharp ME, Holt JG. Baltimore: Williams & Wilkins; 1986:1435–1457. 4. Fukunaga Y, Kurahashi M, Sakiyama Y, Ohuchi M, Yokota A, Harayama S: Phycisphaera check details mikurensis gen. nov., sp. nov., isolated from a marine alga, and proposal of Phycisphaeraceae fam. nov., Phycisphaerales ord. nov. and Phycisphaera classis nov. in the phylum Planctomycetes. J Gen Appl Microbiol 2009, 55:267–275.PubMedCrossRef 5. Fukushi H, Hirai K: Proposal of Chlamydia pecorum sp. nov. for Chlamydia strains derived from ruminants. Int J Syst Evol Microbiol 1992, 42:306–308. 6. Tindall BJ, Rosselló-Móra R, Busse HJ, Ludwig W, Kämpfer P: Notes on the characterization of prokaryote strains for taxonomic purposes. Int J Syst Evol Microbiol 2010, 60:249–266.PubMedCrossRef 7. The Carbohydrate Active

Enzymes database. http://​www.​cazy.​org/​ Phenylethanolamine N-methyltransferase 8. Cantarel BL, Coutinho PM, Rancurel C, Bernard T, Lombard V, Henrissat

B: The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics. Nucleic Acids Res 2009, 37:233–238.CrossRef 9. van Heijenoort J: Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 2001, 11:25–36.CrossRef 10. Boyer M, Madoui MA, Gimenez G, La Scola B, Raoult D: Phylogenetic and phyletic studies of informational genes in genomes highlight existence of a 4th domain of life including giant viruses. PLoS One 2010, 5:e15530.PubMedCrossRef 11. Ezaki T, Kawamura Y, Li N, Li ZY, Zhao L, Shu S: Proposal of the genera Anaerococcus gen. nov., Peptoniphilus gen. nov. and Gallicola gen. nov. for members of the genus Peptostreptococcus. Int J Syst Evol Microbiol 2001, 51:1521–1528.PubMed 12. Ting CS, Hsich C, Sundararaman S, Manella C, Marko M: Cryo-electron tomography reveals the comparative three-dimensional architecture of Prochlorococcus , a globally important marine cyanobacterium. J Bacteriol 2007, 189:4485–4493.PubMedCrossRef 13. Botero LM, Brown KB, Brunefiels S, Burr M, Castenholz RW, Young M, McDermott TR: Thermobaculum terrenum gen. nov., sp. nov. a non phototrophic gram-positive thermophile representing an environmental clone group related to the Chloroflexi (green non-sulfur bacteria) and Thermomicrobia. Arch Microbiol 2004, 181:269–277.PubMedCrossRef 14.

CrossRef 38. Dale RG: The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985, 58:515–528.PubMedCrossRef 39. Douglas BG, Fowler JF: Letter: Fractionation schedules and a quadratic dose-effect relationship. Br J Radiol 1975, 48:502–504.PubMedCrossRef

Competing interests The authors declare that they have no competing interests. Authors’ contributions LB and HE carried out the studies and drafted the manuscript. ME, PD, JFA and FE participated to the experimental studies. JLR participated in the design of the study and in the drafting. JB participated to the irradiation and help to draft the manuscript. JR and RFB participated in the drafting. All authors read and approved the final manuscript.”
“Background At present, identifying

targeted anticancer treatment suitable for a given patient VX-809 cost requires the availability of accurate diagnostics. Diagnostic techniques therefore have a significant impact on patients’ survival and quality of life [1]. In recent years, it has become apparent that certain types of tumors undergo mutations that either originate from the aberrant physiology of the tumor or Selleckchem Tamoxifen are induced/selected by mutagenic cancer therapies [2–4]. Failure to detect mutations in important regulatory genes in tumor specimens may have serious consequences for the patients, because these alterations can significantly reduce the effectiveness Anidulafungin (LY303366) of certain biological and cytotoxic therapies. Mutations in the KRAS oncogene are often found in human cancers. They are most common in pancreatic cancer, which can exhibit mutation rates of 80 – 90%. KRAS mutations are also observed in

40 – 50% of colorectal cancers and 10 – 30% of Non-Small Cell Lung Cancers (NSCLCs). Recent studies have shown that some anticancer drugs are only effective against tumors in which the KRAS signaling pathway has not undergone oncogenic activation. These include the small-molecule epidermal growth factor receptor inhibitors erlotinib (Tarceva®) and gefitinib (Iressa®), which are used to treat NSCLC patients, and monoclonal antibody therapies such as cetuximab (Erbitux®) and panitumumab (Vectibix®), which are primarily used in the treatment of metastatic colorectal cancers (mCRC) [5–7]. According to the U.S. National Comprehensive Cancer Network (NCCN) guidelines from November 2008 ( http://​www.​nccn.​org/​about/​news/​newsinfo.​asp?​NewsID=​194) and recommendations of the American Society of Clinical Oncology (ASCO) [8], screening of the status of the KRAS gene is mandatory when deciding whether or not a patient with colorectal cancer should receive anti-EGFR drugs. Similar rules are being considered for NSCLC where KRAS mutations have prognostic value for progressive disease in adenocarcinoma [9, 10]. There are multiple methods for detecting KRAS mutations in patient tissues, with varying analytical parameters.

In contrast, the T. brucei TRF protein

(TbTRF) appears to co-localize with most telomeres at all stages of the cell cycle in both bloodstream and procyclic forms [24]. Whether LaTRF also has other cellular roles or if its association with telomeres occurs in a cell cycle dependent manner is not clear at this stage. Figure 3 LaTRF partially co-localizes with L. amazonensis telomeres. LaTRF (red), using anti-LaTRF serum, was combined with FISH (green) using a PNA-telomere probe specific for TTAGGG repeats. DAPI (blue) was used to stain DNA in the nucleus (N) and in the kinetoplast ABT-263 clinical trial (K). Images were organized in panels p1-p4 showing the co-localization patterns in merged (a): telomeres and LaTRF, and in merged (b): DAPI, telomeres and LaTRF. Merged images were done using NIS elements software (v. Br 2.30). LaTRF interacts in vitro and in vivo with L. amazonensis telomeres using a Myb-like DNA binding domain EMSA assays were done with renatured protein extracts containing full length LaTRF, the Myb-like DNA binding domain (LaTRFMyb) (Figs 4 and 5, see additional file 1) and with L. amazonensis nuclear extracts (Fig 6), to investigate whether LaTRF, like its vertebrate and trypanosome counterparts [18, 24], was able to bind double-stranded telomeric DNA in vitro. Figure 4 Recombinant LaTRF and the mutant bearing

the C-terminal Myb domain bind in vitro double-stranded telomeric DNA. Electrophoretic LDK378 mobility shift assays (EMSA) were done using radiolabeled double-stranded telomeric DNA (LaTEL) as probe. Protein:DNA complexes were separated in a 4% PAGE in 1X TBE. EMSA was done with E. coli BL21 protein extract (lane 2), recombinant full length LaTRF (lanes 3-6) and a mutant bearing the C-terminal Myb domain (lanes 7-9). A supershift assay Protein kinase N1 was done with anti-LaTRF serum (lane 6). Assays were also done in the presence of 20 fold excess of non-labeled LaTEL as specific competitor (lanes 4 and 8) or 100 fold excess of double-stranded non-specific poly [dI-dC] [dI-dC] DNA (lanes 5 and 9). In lane 1, no protein was

added to the binding reaction. The original gel image and its content are shown as additional file 1: Figure S1. Figure 5 Supershift and competition assays confirm that recombinant full length LaTRF bind in vitro double-stranded telomeric DNA. Electrophoretic mobility shift assays (EMSA) were done using radiolabeled double-stranded telomeric DNA (LaTEL) as probe. Protein:DNA complexes were separated in a 4% PAGE in 1X TBE. EMSA was done with recombinant full length LaTRF and anti-LaTRF serum in the absence (lane 2) and in the presence of 20 fold excess of non-labeled LaTEL as specific competitor (lane 3) or 100 fold excess of double-stranded non-specific DNA (poly [dI-dC] [dI-dC]) as non specific competitor (lane 4).

Figure 1 Cell-associated hemolytic activity (cHA). Cell-associated hemolytic activity (cHA) was measured as described in the materials and methods. Results are mean values from at least three independent experiments. Standard deviation is shown. RBCs were incubated 1h at 37°C with MFN1032, MFY63, MFY70, MFY162, SBW25, C7R12, MF37 or DC3000 cultivated at 28°C (MOI of

1). The same panel of strains Bortezomib datasheet was tested on tobacco leaves to determine if these strains were able to induce HR. As illustrated in Figure 2, HR was only detected for C7R12 and DC3000. All clinical strains i.e., MFY63, MFY70, MFY162 and MFN1032 and two environmental strains, SBW25 and MF37, were unable to induce HR. Figure 2 Plant hypersensitive response (HR) assay. P. fluorescens strains, MFN1032, MFY63, MFY70, MFY162, SBW25, C7R12, MF37 and P. syringae DC3000, were infiltrated into Nicotiana tabacum cv. leaves. The leaves were evaluated for production of HR and were photographed after 48 h. This experiment

was repeated 2 times with similar results. P. fluorescens MFN1032 is virulent on Dictyostelium discoideum (D. discoideum) As described in Figure 3A, Klebsiella aerogenes (KA) (negative control for virulence), Pseudomonas aeruginosa PA14 (positive control for virulence), and MFN1032 were tested on D. discoideum. On a layer of KA, about one hundred lysis plaques were observed, corresponding this website to the zone where actively feeding and replicating D. discoideum have phagocytosed the bacteria. On a layer of PA14 or MFN1032 at 10%, no lysis plaque was detected. MFN1032 does indeed display a virulent phenotype on D. discoideum, either by evading D. discoideum killing, or by actively killing

amoebae. Then, our panel of strains was tested on D. discoideum (Figure 3B). Two strains, C7R12 and MF37 had a complete absence of D. discoideum growth inhibition (100% of D. discoideum remained). MFY63 and SBW25 were highly permissive for D. discoideum growth (90% and 75% of amoebae remained, respectively). MFY70 Dolichyl-phosphate-mannose-protein mannosyltransferase and MFY162 permitted the replication of about half of the D. discoideum (40% and 60% respectively). DC3000 had a slightly virulent phenotype on D. discoideum (20% of D. discoideum remained). In our panel, to small to be representative, D. discoideum growth inhibition above 50% was only observed for clinical or phytopathogenic strains of Pseudomonas. Figure 3 Virulence towards Dictyostelium discoideum. Approximately 100 D. discoideum cells were cultivated in SM-plates with the indicated proportion of Klebsiella aerogenes and Pseudomonas strains (10%). Plates were maintained at 22°C for 5 days. A: Pseudomonas aeruginosa PA14 (positive control), Klebsiella aerogenes (KA, negative control) and P. fluorescens MFN1032 virulence towards D. discoideum after 5 days. B: Virulence of different Pseudomonas strains at 10% against D. discoideum. These results were obtained by the ratio of the number of lysis plaques obtained with the negative control Klebsiella aerogenes (100% of amoebae remained).

This work was performed under the auspices of the US Department of Energy by the University of California, Lawrence Livermore National Laboratory under Contract No. W-7405-Eng-48, with support from the Department of Homeland Security (Biological Countermeasures Program). The authors would also like to thank PSW RCE Animal Resources and Laboratory Services Core U54-AI65359. UCRL-JRNL-212527. References 1. Bossi P, Bricaire F, et al.: Bioterrorism: Selleckchem LY294002 management of major biological agents. Cell Mol Life Sci 2006, 63:2196–2212.PubMedCrossRef 2. Inglesby TV, et al.: Plague as a biological

weapon: medical and public health management, Working Group on Civilian Biodefense. JAMA 2000, 283:2281–2290.PubMedCrossRef 3. Stenseth NC, et al.: Plague: past, present, and future. PLoS Med 2008, 5:e3.PubMedCrossRef 4. Lee VT, Schneewind this website O: Protein secretion and the pathogenesis of bacterial infections. Genes Dev 2001, 15:1725–1752.PubMedCrossRef 5. Perry RD, Fetherston JD: Yersinia pestis–etiologic agent of plague. Clin Microbiol Rev 1997, 10:35–66.PubMed 6. Matsumoto H, Young GM: Translocated effectors of Yersinia. Curr Opin Microbiol 2009, 12:94–100.PubMedCrossRef 7. Cornelis GR: Yersinia type III secretion: send in the effectors. J Cell Biol 2002, 158:401–408.PubMedCrossRef 8. Stebbins CE, Galan JE: Structural mimicry in bacterial virulence. Nature 2001, 412:701–705.PubMedCrossRef 9. Kutyrev

V, et al.: Expression of the plague plasminogen activator in Yersinia pseudotuberculosis and Escherichia coli. Infect Immun 1999, 67:1359–1367.PubMed 10. Cornelis GR: The Yersinia Ysc-Yop ‘type III’ weaponry. Nat Rev Mol Cell Biol 2002, 3:742–752.PubMedCrossRef 11. Achtman M, et al.: Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A 1999, 96:14043–14048.PubMedCrossRef 12. Turnbull PC: Introduction: anthrax history,

disease and ecology. Curr Top Microbiol Immunol 2002, 271:1–19.PubMed 13. Passalacqua KD, Bergman NH: Bacillus anthracis: interactions with the host and establishment of inhalational anthrax. Future Microbiol 2006, 1:397–415.PubMedCrossRef 14. Hugh-Jones M: 1996–97 Global Anthrax Report. J Appl Microbiol 1999, 87:189–191.PubMedCrossRef 15. Kaspar RL, Robertson DL: Purification and physical analysis of Bacillus anthracis Janus kinase (JAK) plasmids pXO1 and pXO2. Biochem Biophys Res Commun 1987, 149:362–368.PubMedCrossRef 16. Pickering AK, et al.: Cytokine response to infection with Bacillus anthracis spores. Infect Immun 2004, 72:6382–6389.PubMedCrossRef 17. Lathem WW, et al.: Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci U S A 2005, 102:17786–17791.PubMedCrossRef 18. Cross ML, et al.: Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteriaFEMS Immunol. Med. Microbiol. 2004,42(2):173–180. 19. Mathiak G, et al.

FEMS Microbiol Ecol 2011, 75:28–36.PubMedCrossRef 50. Gamer J, Multhaup G, Tomoyasu T, McCarty JS, Rudiger S, Schonfeld HJ, Schirra C, Bujard H, Bukau BA: A cycle of binding and release of the DnaK, DnaJ and GrpE chaperones regulates the activity of the Escherichia coli heat shock transcription factor sigma32. EMBO J 1996, 15:607–617.PubMed 51. Gross CA: Function and regulation of the heat shock proteins. In Escherichia coli and Samonella. Edited by: Neidhard FC. ASM Press, Washington DC; 1996:1382–1399. 52. Fayet O, Ziegelhoffer T, Georgopoulos C: The groES and groEL heat shock gene products of Escherichia coli are essential for bacterial growth at all temperatures. J Bacteriol 1989,

171:1379–1385.PubMed Selleck MLN0128 53. Periago PM, Van Schaik W, Abee T, Wouters JA: Identification of proteins involved in the heat stress response of Bacillus cereus ATCC 14579. Appl Environ Microbiol 2002, 68:3486–3495.PubMedCrossRef 54. Cardoso IWR-1 molecular weight K, Gandra RF, Wisniewski ES, Osaku CA, Kadowaki MK, Felipach-Neto V, Haus LFA, Simão RCG: DnaK and GroEL are induced in response to antibiotic and heat shock in Acinetobacter baumannii. J Med Microbiol 2010, 59:1061–1068.PubMedCrossRef 55. Goloubinoff P, Christeller

JT, Gatenby AA, Lorimer GH: Reconstitution of active dimeric ribulose bisphosphate carboxylase from an unfolded state depends on two chaperonin proteins and Mg-ATP. Nature 1989, 342:884–889.PubMedCrossRef 56. Sigler PB, Xu Z, Rye HS, Burston SG, Fenton WA, Horwich AL: Structure and function in GroEL mediated protein folding. Annu Rev Biochem 1998, 67:581–608.PubMedCrossRef 57. Caldas TD, Yaagoubi A, Richarme G: Chaperone properties of bacterial elongation factor EF-Tu. J Biol Chem 1998, 273:11478–11482.PubMedCrossRef 58. Caldas T, Laalami S, Richarme G: Chaperone properties Vasopressin Receptor of bacterial elongation factor EF-G and initiation factor IF2. J Biol Chem 2000, 275:855–860.PubMedCrossRef 59. Brot N: Translation. In Molecular Mechanisms of Protein Synthesis. Edited by: Weissbach H, Pestka S. Academic,

New York; 1977:375–411. 60. Hendrick JP, Hartl FU: Molecular chaperone functions of heat shock proteins. Annu Rev Biochem 1993, 62:349–384.PubMedCrossRef 61. Jacobson GR, Rosenbuch JP: Abundance and membrane association of elongation factor Tu in E. coli. Nature 1976, 261:23–26.PubMedCrossRef 62. Kudlicki W, Coffman A, Kramer G, Hardesty B: Renaturation of rhodanese by translational elongation factor (EF) Tu – protein refolding by EF-Tu flexing. J Biol Chem 1997, 272:32206–32210.PubMedCrossRef 63. Grunberg-Manago M: Escherichia coli and Salmonella typhimurium Cellular and Molecular biology. 2nd edition. Edited by: Neidhardt FC. ASM Press, Washington, DC; 1996:1432–1457. 64. Nanda AK, Andrio E, Marino D, Pauly N, Dunand C: Reactive Oxygen Species during Plant-microorganism Early Interactions. J Integr Plant Biol 2010, 52:195–204.PubMedCrossRef 65.

Taiwania 51:87–92 Mrosovsky N (1988) The CITES conservation circus. Nature 331:563CrossRef Nijman V (2005) In full swing. An assessment of trade in orang-utans and gibbons on Java and Bali, Indonesia. TRAFFIC Southeast Asia, Petaling Jaya Nijman V (2006) In situ and ex situ status of the Javan gibbon and the role of zoos in conservation of the species. Contrib Zool 75(3–4):161–168 Nijman V (2010) An overview

of the international wildlife trade from Southeast Asia. Biodivers Conserv (special issue: conserving Southeast Asia’s imperiled biodiversity). doi:10.​1007/​s10531-009-9758-4 Nijman V, Shepherd CR (2007) Trade in non-native, CITES-listed, wildlife in Asia, as exemplified by the trade in freshwater turtles and tortoises (Chelonidae) in Thailand. Contrib Zool 76:207–211 Pickett J (1987) Poison arrow frogs, CITES, and other interesting matters. British Herpetol Bcl-2 inhibitor Soc Bull 21:58–59 Preece DJ (1998) The captive management and breeding of poison-dart frogs, family Dendrobatidae, MK-1775 price at Jersey Wildlife Preservation Trust. Dodo 34:103–114 Schlaepfer MA, Hoover C, Dodd CK (2005) Challenges in evaluating the impact of

the trade in amphibians and reptiles on wild populations. Bioscience 55:256–264CrossRef Shepherd CR, Sukumaran J, Wich SA (2004) Open season: an analysis of the pet trade in Medan, Sumatra 1997–2001. TRAFFIC Southeast Asia, Petaling Jaya Symula R, Schulte R, Summers K (2003) Molecular systematics and phylogeography of Amazonian poison frogs of the genus Dendrobates.

Mol Phylogenet Evol 26:452–475CrossRefPubMed Vences M, Kosuch J, Lötters S, Widmer A, Köhler J, Jungfer K-H, Veith M (2000) Phylogeny and classification of poison frogs (Amphibia: Dendrobatidae), based on mitochondrial 16S and 12S ribosomal RNA gene sequences. Mol Phylogenet Evol 15:34–40CrossRefPubMed Footnotes 1 It is quite possible that some or even most of the D. amazonicus in trade are in fact the Ribose-5-phosphate isomerase red morph of D. ventrimaculatus, labelled as the former so as to increase their value (Victor J.T. Loehr, in litt.).”
“Introduction Species distribution patterns enable scientists and conservation planners to estimate centers of biodiversity (e.g. Williams et al. 1996; Kress et al. 1998; Barthlott et al. 2005) and to identify priority areas for conservation actions (e.g. Davis et al. 1997; de Oliveira and Daly 1999; Schatz 2002; Tobler et al. 2007). Species confined to very small distribution areas, so-called narrow endemic species (Williams et al. 1996; Andersen et al. 1997), pose important conservation issues due to their vulnerability to extinction (Gentry 1986; Knapp 2002). Due to insufficient data collection and heterogeneous sampling effort, distribution patterns in the Neotropics are still poorly described (Kress et al. 1998; Bates and Demos 2001; Hopkins 2007; Morawetz and Raedig 2007).

2 mM of the drug (Figure 5D-F). We detected important decrease in the microfilament density in the peripheral cytoplasm and an accumulation of fragmented F-actin near the nucleus in HT-144 cells treated with the higher drug concentration. Figure 5 Effects of cinnamic acid on microfilaments organization of HT-144 cells. Images obtained by Laser Scanning Confocal Microscopy of phalloidin FITC-conjugated staining (green) preparations: A,B,C) HT-144 control cells; D,E,F) HT-144 cells treated Panobinostat order with 3.2 mM cinnamic acid. DNA was counterstained with propidium iodide (red). Note the stress fiber formation in control cells (above) and the decreasing of peripheral actin filaments

and perinuclear accumulation of F-actin in treated groups

(below). Figure 6 Cytoskeleton organization in NGM control cells. F-actin (green) was stained with phalloidin FITC-conjugated. Microtubules (blue) were labeled with anti-α and β tubulin and secondary antibody CY-5-conjugated. DNA was counterstained with propidium iodide (red). Note the stress fiber formation (actin filaments). The cells showed a microtubule network that was very finely departed from the centrosome region near the nucleus. We can also observe a mitotic cell (right column). The images were obtained by Laser Scanning Confocal Microscopy. We also observed microtubule disruption in HT-144 cells after treatment with cinnamic acid. Cells treated with 0.4 mM cinnamic acid maintained a normal distribution of microtubules, whereas treatment Kinase Inhibitor Library cost with 3.2 mM induced very diffuse labeling in the cytoplasm with accumulation around the cell

nuclei (Figure 7). Figure 7 Effects of cinnamic acid on microtubules organization of HT-144 cells. Images obtained by Laser Scanning Confocal Microscopy of anti-tubulin immunofluorescence (blue) preparations: A) interphasic HT-144 control cells; B) mitotic HT-144 control cell; C,D) HT-144 cells treated with 3.2 mM cinnamic acid. DNA was counterstained with propidium iodide (red). We can observe 3-oxoacyl-(acyl-carrier-protein) reductase cells with a microtubule network that was very finely departed from the centrosome region near the nucleus (up left) and a normal mitosis (up right). On the other hand, we found cells with microtubule disorganization and tubulin bunches near the nuclei. Treatment with 3.2 mM cinnamic acid induced robust morphological changes in some NGM cells. In addition to changes that occurred in less than 2% of the cases, a cytoskeletal analysis revealed the presence of coiled actin filaments and microtubules (Figure 8). Moreover, the nuclei exhibited an alteration in their morphology, which were observed in NGM cells that were treated with 3.2 mM cinnamic acid; however, a low frequency was observed when compared to HT-144 cells. There was no cytoskeleton reorganization in the NGM cells treated with 0.4 mM of the drug. Figure 8 Cytoskeleton organization in NGM cells treated with 3.2 mM cinnamic acid. The cells were treated with the drug for 48 hours.